Rothenberg Mace has filed 9 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 37500 shares of Tango Therapeutics, Inc. ($TNGX) on June 05, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Tango Therapeutics, Inc. | $TNGX | Rothenberg Mace | Not found | A | Stock Option (Right to Buy) | 37500 | $0.00 | 37,500.0000 | 108,107,890 | 9999.99% | 0.03% |
| June 5, 2025 | Tango Therapeutics, Inc. | $TNGX | Rothenberg Mace | Not found | A | Common Stock | 6250 | $0.00 | 37,500.0000 | 108,107,890 | 20.00% | 0.01% |
| May 14, 2025 | Surrozen, Inc./DE | $SRZN | Rothenberg Mace | Not found | A | Option (right to buy) | 1333 | $0.00 | 1,333.0000 | 3,281,169 | 9999.99% | 0.04% |
| Nov. 14, 2024 | Tango Therapeutics, Inc. | $TNGX | Rothenberg Mace | Not found | P | Common Stock | 10000 | $3.62 | 21,250.0000 | 0 | 88.89% | 0.00% |
| Nov. 18, 2024 | Tango Therapeutics, Inc. | $TNGX | Rothenberg Mace | Not found | P | Common Stock | 10000 | $3.78 | 31,250.0000 | 0 | 47.06% | 0.00% |
| June 5, 2024 | Tango Therapeutics, Inc. | $TNGX | Rothenberg Mace | Not found | A | Common Stock | 6250 | $0.00 | 11,250.0000 | 0 | 125.00% | 0.00% |
| June 5, 2024 | Tango Therapeutics, Inc. | $TNGX | Rothenberg Mace | Not found | A | Stock Option (Right to Buy) | 37500 | $0.00 | 37,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Surrozen, Inc./DE | $SRZN | Rothenberg Mace | Not found | A | Option (right to buy) | 1333 | $0.00 | 1,333.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Surrozen, Inc./DE | $SRZN | Rothenberg Mace | Not found | A | Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |